| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $1.0B | $0.6B | $0.7B | $0.7B | $0.5B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.3B | $0.3B | $0.3B | $0.2B | $0.3B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $5.11 | $4.43 | $4.40 | $3.50 | $5.71 | $1.20 | $0.88 | $0.94 |
| EPS (Diluted) | $5.09 | $4.41 | $4.40 | $3.49 | $5.69 | $1.20 | $0.88 | $0.93 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $21.3B | $20.8B | $20.6B | $19.9B | $15.8B | $14.3B | $12.3B | $7.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.7B | $1.2B | $1.1B | $0.8B | $1.5B | $1.7B | $0.6B | $0.6B |
| Total Liabilities | $18.6B | $18.2B | $18.1B | $17.7B | $13.8B | $12.5B | $10.4B | $6.4B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.7B | $2.6B | $2.5B | $2.2B | $1.9B | $1.8B | $1.9B | $0.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.2B | $0.2B | $0.5B | $0.1B | $0.0B | $0.1B | $0.1B |
| Investing Cash Flow | $0.1B | $-0.1B | $-0.3B | $-0.1B | $-1.5B | $-0.9B | $0.3B | $-0.4B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.2B | $-0.1B | $0.3B | $-1.0B | $1.2B | $1.9B | $-0.4B | $0.1B |